SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Linda Kaplan who wrote (6390)4/12/1999 4:26:00 PM
From: Diamondcutter  Read Replies (2) of 7041
 
I didn't edit out "all the negatives"--in my opinion, any delay in the FDA decision (from the company's perspective) is not good. I also didn't want to repeat what (I think you?) had already posted (which contained its share of negatives). All my post was intended to do was give a summary regarding the "meeting" comments, for which there was some confusion.

Regarding the "additional studies", since there has been minimal concern regarding Vasomax's safety (especially versus viagra), I would have been surprised if any issues had cropped up in the additional trials. So, I wouldn't have jumped to the conclusion you made regarding how convincing the additional data had to be.

diamondcutter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext